# Medtronic plc (MDT) FY2025 Annual P&L / Income Statement - Company: Medtronic plc (MDT) - Period: 2024-04-27 to 2025-04-25 - Filing: FY2025 10-K, filed 2025-06-20, accession number 0001613103-25-000091 - Page: https://plicit.ai/financials/mdt/fy2025-annual-income-statement - Chart image: https://plicit.ai/charts/mdt-fy2025-annual-income-statement-sankey.png ## Chart details: Revenue by Business Segment by Subsegment Income statement for 2024-04-27 through 2025-04-25. View: Segments by Subsegments. Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Net sales**: 33,537,000,000 US dollars - **Cost of products sold, excluding amortization of intangible assets**: 11,632,000,000 US dollars - **Gross profit (calculated)**: 21,905,000,000 US dollars - **Operating costs, net of other operating income (calculated)**: 15,949,000,000 US dollars - **Operating profit**: 5,955,000,000 US dollars - **Other income (expense), net (calculated)**: negative 327,000,000 US dollars - **Income before income taxes**: 5,628,000,000 US dollars - **Income tax provision**: 936,000,000 US dollars - **Net income**: 4,691,000,000 US dollars - **Diabetes**: 2,755,000,000 US dollars - **Other operating segment**: 137,000,000 US dollars - **Cardiovascular - Cardiac Rhythm & Heart Failure**: 6,392,000,000 US dollars - **Cardiovascular - Coronary & Peripheral Vascular**: 2,535,000,000 US dollars - **Cardiovascular - Structural Heart & Aortic**: 3,554,000,000 US dollars - **Medical Surgical - Acute Care & Monitoring**: 1,909,000,000 US dollars - **Medical Surgical - Surgical & Endoscopy**: 6,498,000,000 US dollars - **Neuroscience - Cranial & Spinal Technologies**: 4,973,000,000 US dollars - **Neuroscience - Neuromodulation**: 1,932,000,000 US dollars - **Neuroscience - Specialty Therapies**: 2,940,000,000 US dollars - **Research and development expense**: 2,732,000,000 US dollars - **Selling, general, and administrative expense**: 10,849,000,000 US dollars - **Amortization of intangible assets**: 1,807,000,000 US dollars - **Restructuring charges, net**: 267,000,000 US dollars - **Certain litigation charges, net**: 317,000,000 US dollars - **Other operating (income) expense, net**: negative 23,000,000 US dollars - **Revenue before reconciliation (calculated)**: 33,625,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation. - **Components above reported revenue (calculated)**: negative 88,000,000 US dollars. The disclosed components add up to more than reported revenue; this is the difference, calculated, not a reported item. ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. - Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue. - Of which attributable to Medtronic plc: $4.66 B; to noncontrolling interests: $29.00 M. - The amounts that make up operating profit come to $5,956.00 M and operating profit is $5,955.00 M; the $1.00 M difference is within the rounding of the filed amounts. - The amounts that make up net income come to $4,692.00 M and net income is $4,691.00 M; the $1.00 M difference is within the rounding of the filed amounts. ## Chart details: Revenue by Geography (3 categories) - Page: https://plicit.ai/financials/mdt/fy2025-annual-income-statement/revenue-by-geography-3-categories - Chart image: https://plicit.ai/charts/mdt-fy2025-annual-revenue-by-geography-3-categories-sankey.png Income statement for 2024-04-27 through 2025-04-25. View: Geography (3 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Net sales**: 33,537,000,000 US dollars - **Cost of products sold, excluding amortization of intangible assets**: 11,632,000,000 US dollars - **Gross profit (calculated)**: 21,905,000,000 US dollars - **Operating costs, net of other operating income (calculated)**: 15,949,000,000 US dollars - **Operating profit**: 5,955,000,000 US dollars - **Other income (expense), net (calculated)**: negative 327,000,000 US dollars - **Income before income taxes**: 5,628,000,000 US dollars - **Income tax provision**: 936,000,000 US dollars - **Net income**: 4,691,000,000 US dollars - **UNITED STATES**: 17,171,000,000 US dollars - **Rest of world**: 16,250,000,000 US dollars - **IRELAND**: 116,000,000 US dollars - **Research and development expense**: 2,732,000,000 US dollars - **Selling, general, and administrative expense**: 10,849,000,000 US dollars - **Amortization of intangible assets**: 1,807,000,000 US dollars - **Restructuring charges, net**: 267,000,000 US dollars - **Certain litigation charges, net**: 317,000,000 US dollars - **Other operating (income) expense, net**: negative 23,000,000 US dollars ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. - Of which attributable to Medtronic plc: $4.66 B; to noncontrolling interests: $29.00 M. - The amounts that make up operating profit come to $5,956.00 M and operating profit is $5,955.00 M; the $1.00 M difference is within the rounding of the filed amounts. - The amounts that make up net income come to $4,692.00 M and net income is $4,691.00 M; the $1.00 M difference is within the rounding of the filed amounts. ## Chart details: Revenue by Business Segment (4 categories) - Page: https://plicit.ai/financials/mdt/fy2025-annual-income-statement/revenue-by-business-segment-4-categories - Chart image: https://plicit.ai/charts/mdt-fy2025-annual-revenue-by-business-segment-4-categories-sankey.png Income statement for 2024-04-27 through 2025-04-25. View: Business segment (4 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Net sales**: 33,537,000,000 US dollars - **Cost of products sold, excluding amortization of intangible assets**: 11,632,000,000 US dollars - **Gross profit (calculated)**: 21,905,000,000 US dollars - **Operating costs, net of other operating income (calculated)**: 15,949,000,000 US dollars - **Operating profit**: 5,955,000,000 US dollars - **Other income (expense), net (calculated)**: negative 327,000,000 US dollars - **Income before income taxes**: 5,628,000,000 US dollars - **Income tax provision**: 936,000,000 US dollars - **Net income**: 4,691,000,000 US dollars - **Cardiovascular**: 12,481,000,000 US dollars - **Neuroscience**: 9,846,000,000 US dollars - **Medical Surgical**: 8,407,000,000 US dollars - **Diabetes**: 2,755,000,000 US dollars - **Undisclosed (calculated)**: 48,000,000 US dollars - **Research and development expense**: 2,732,000,000 US dollars - **Selling, general, and administrative expense**: 10,849,000,000 US dollars - **Amortization of intangible assets**: 1,807,000,000 US dollars - **Restructuring charges, net**: 267,000,000 US dollars - **Certain litigation charges, net**: 317,000,000 US dollars - **Other operating (income) expense, net**: negative 23,000,000 US dollars ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. - Of which attributable to Medtronic plc: $4.66 B; to noncontrolling interests: $29.00 M. - The amounts that make up operating profit come to $5,956.00 M and operating profit is $5,955.00 M; the $1.00 M difference is within the rounding of the filed amounts. - The amounts that make up net income come to $4,692.00 M and net income is $4,691.00 M; the $1.00 M difference is within the rounding of the filed amounts. ## Chart details: Revenue by Geography (2 categories) - Page: https://plicit.ai/financials/mdt/fy2025-annual-income-statement/revenue-by-geography-2-categories - Chart image: https://plicit.ai/charts/mdt-fy2025-annual-revenue-by-geography-2-categories-sankey.png Income statement for 2024-04-27 through 2025-04-25. View: Geography (2 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Net sales**: 33,537,000,000 US dollars - **Cost of products sold, excluding amortization of intangible assets**: 11,632,000,000 US dollars - **Gross profit (calculated)**: 21,905,000,000 US dollars - **Operating costs, net of other operating income (calculated)**: 15,949,000,000 US dollars - **Operating profit**: 5,955,000,000 US dollars - **Other income (expense), net (calculated)**: negative 327,000,000 US dollars - **Income before income taxes**: 5,628,000,000 US dollars - **Income tax provision**: 936,000,000 US dollars - **Net income**: 4,691,000,000 US dollars - **UNITED STATES**: 17,171,000,000 US dollars - **International**: 16,365,000,000 US dollars - **Undisclosed (calculated)**: 1,000,000 US dollars - **Research and development expense**: 2,732,000,000 US dollars - **Selling, general, and administrative expense**: 10,849,000,000 US dollars - **Amortization of intangible assets**: 1,807,000,000 US dollars - **Restructuring charges, net**: 267,000,000 US dollars - **Certain litigation charges, net**: 317,000,000 US dollars - **Other operating (income) expense, net**: negative 23,000,000 US dollars ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. - Of which attributable to Medtronic plc: $4.66 B; to noncontrolling interests: $29.00 M. - The amounts that make up operating profit come to $5,956.00 M and operating profit is $5,955.00 M; the $1.00 M difference is within the rounding of the filed amounts. - The amounts that make up net income come to $4,692.00 M and net income is $4,691.00 M; the $1.00 M difference is within the rounding of the filed amounts. ## Chart details: Revenue by Business Segment (6 categories) - Page: https://plicit.ai/financials/mdt/fy2025-annual-income-statement/revenue-by-business-segment-6-categories - Chart image: https://plicit.ai/charts/mdt-fy2025-annual-revenue-by-business-segment-6-categories-sankey.png Income statement for 2024-04-27 through 2025-04-25. View: Business segment (6 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Net sales**: 33,537,000,000 US dollars - **Cost of products sold, excluding amortization of intangible assets**: 11,632,000,000 US dollars - **Gross profit (calculated)**: 21,905,000,000 US dollars - **Operating costs, net of other operating income (calculated)**: 15,949,000,000 US dollars - **Operating profit**: 5,955,000,000 US dollars - **Other income (expense), net (calculated)**: negative 327,000,000 US dollars - **Income before income taxes**: 5,628,000,000 US dollars - **Income tax provision**: 936,000,000 US dollars - **Net income**: 4,691,000,000 US dollars - **Cardiovascular**: 12,481,000,000 US dollars - **Neuroscience**: 9,846,000,000 US dollars - **Medical Surgical**: 8,407,000,000 US dollars - **Diabetes**: 2,755,000,000 US dollars - **Other operating segment**: 137,000,000 US dollars - **Rounding (calculated)**: 1,000,000 US dollars - **Research and development expense**: 2,732,000,000 US dollars - **Selling, general, and administrative expense**: 10,849,000,000 US dollars - **Amortization of intangible assets**: 1,807,000,000 US dollars - **Restructuring charges, net**: 267,000,000 US dollars - **Certain litigation charges, net**: 317,000,000 US dollars - **Other operating (income) expense, net**: negative 23,000,000 US dollars - **Revenue before reconciliation (calculated)**: 33,627,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation. - **Consolidation, Eliminations**: negative 90,000,000 US dollars. Reported reconciliation to consolidated revenue. ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. - Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue. - Of which attributable to Medtronic plc: $4.66 B; to noncontrolling interests: $29.00 M. - The amounts that make up operating profit come to $5,956.00 M and operating profit is $5,955.00 M; the $1.00 M difference is within the rounding of the filed amounts. - The amounts that make up net income come to $4,692.00 M and net income is $4,691.00 M; the $1.00 M difference is within the rounding of the filed amounts.